D-Pearls

Quick links to important sections

D-Pearls

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of D-Pearls

Quick Facts

Property Description
Active ingredient Colecalciferol (Vitamin D3)
Form Soft gelatin capsules (Pearls)
Pharmacological class Vitamin preparation (Fat-soluble vitamin)
General purpose Support of skeletal health and calcium homeostasis
Origin Derived substance (Natural-derived)

What is D-Pearls and its Core Identity?

The preparation D-Pearls is fundamentally a Colecalciferol preparation, chemically synonymous with Vitamin D3, categorized within the pharmacological class of vitamin preparations, specifically defined as a fat-soluble vitamin. It is characterized as a single-ingredient product, offering a focused source of this essential micronutrient. Colecalciferol is biologically the same form of Vitamin D naturally generated in human skin through UVB exposure. A primary action of Colecalciferol is regulating the absorption and utilization of calcium and phosphate in the body.


Composition and The Function of Soft Gelatin Capsules

This preparation utilizes the soft gelatin capsule as its specific oral dosage form, frequently referenced as Pearls due to their small, easily swallowed shape. This structure is critical for effective delivery because, as a fat-soluble vitamin, Colecalciferol requires a lipid environment for efficient uptake into the body's systems. Consequently, the active ingredient is dissolved within a high-quality carrier oil, such as cold-pressed olive oil, before being encapsulated. This specific oil-based composition ensures enhanced bioavailability and promotes the predictable absorption of the nutrient, distinguishing the product from non-oil-based dry formulations.


What is the General Physiological Purpose of D-Pearls?

The overarching purpose of utilizing this preparation is the fundamental support of skeletal health and the efficient maintenance of mineral homeostasis. By acting as a calcium absorption regulator, Colecalciferol ensures that the necessary levels of calcium and phosphate are available for proper bone tissue mineralization. Furthermore, the substance is widely acknowledged for its supportive role in normal muscle function and the general competency of the immune system, positioning the preparation as a foundational agent essential for supporting multiple systemic functions.

What side effects are possible with D-Pearls?

Possible side effects and safety information

The official regulatory safety profile for Colecalciferol (Vitamin D3) is primarily structured around the potential for toxicity resulting from systemic accumulation, specifically hypervitaminosis D and the resulting electrolyte imbalance of hypercalcaemia (high blood calcium).

Adverse reactions listed in regulatory documents are generally associated with overdose rather than appropriate therapeutic supplementation. These are categorized by frequency, with the most common being the metabolic effects:

Classification Adverse Reactions System-Organ Class
Uncommon Hypercalcaemia (high blood calcium) and Hypercalciuria (high urine calcium) Metabolism and Nutrition Disorders
Rare Gastrointestinal symptoms (e.g., nausea, abdominal pain, constipation); Skin reactions (e.g., rash, pruritus, urticaria) Gastrointestinal Disorders; Skin and Subcutaneous Tissue Disorders

The serious adverse reactions documented by regulatory authorities are typically consequences of prolonged toxicity. These include the potential for kidney failure, nephrolithiasis (kidney stones), and cardiac rhythm disturbances (cardiac arrhythmias). The effects of toxicity may persist for several weeks following cessation of high intake.

Safety Considerations and Restrictions

Official labeling defines specific safety limitations. The preparation is contraindicated (should not be used) in patients with pre-existing conditions such as hypercalcaemia, hypervitaminosis D, nephrocalcinosis (kidney calcification), or severe renal impairment.

Population-specific notes also exist; for example, infants and children are noted as being more susceptible to toxic effects. In high-risk patients, official documents recommend the monitoring of serum and urinary calcium levels during treatment to maintain safety.

Overdose and Emergency Response

The official regulatory profile for Colecalciferol (D-Pearls) overdose centers on the condition of hypercalcemia (excessively high calcium levels), which arises from consuming high or prolonged doses. The documented manifestations of this toxicity include initial symptoms such as nausea, vomiting, constipation, anorexia, fatigue, and general weakness. Other recognized signs involve the urinary and neurological systems, such as polydipsia (excessive thirst), polyuria (frequent urination), and confusion.

The regulatory documents emphasize that overdose is a serious risk that can lead to life-threatening outcomes. These severe consequences are officially documented to include renal impairment that may progress to renal failure or nephrocalcinosis, as well as dangerous cardiac arrhythmias.

Due to these severe risks, immediate medical attention must be sought if an overdose is suspected. The primary emergency response includes the mandatory discontinuation of Colecalciferol and any accompanying calcium supplements. Treatment is defined as symptomatic and supportive, aiming to reduce serum calcium through measures like rehydration. Official labeling confirms that no specific antidote is known. Continuous monitoring of serum calcium levels and renal function is required during management. Patients with pre-existing impaired renal function, as well as infants and children, are noted in regulatory information as potentially more vulnerable to severe effects.

Therapeutic Uses of D-Pearls

The therapeutic profile of D-Pearls (Colecalciferol) is considered relevant to supporting core physiological functions, particularly mineral balance and skeletal health. The preparation is commonly used to help with managing or addressing deficiencies and associated conditions.

This preparation is generally used for managing or addressing deficiencies that lead to skeletal weakness, including rickets, osteomalacia, and osteoporosis. The systemic benefits are centered on easing diffuse bone pain and addressing chronic muscle aches and proximal muscle weakness. Supporting normal muscle function may assist with fall prevention in high-risk patient groups.

“This substance plays a role in managing musculoskeletal discomfort and is relevant in supportive therapy for bone integrity.”

D-Pearls is applied when appropriate in clinical scenarios such as in patients with malabsorption disorders or those needing seasonal supplementation. This corrective use may assist with supporting mineral homeostasis and general well-being.


Quick Fact: Support for Musculoskeletal Discomfort

Therapeutic Area Primary Symptom/Condition Patient Benefit
Skeletal Health Deficiency, Osteoporosis Helps support bone mineral density
Musculoskeletal Muscle weakness, Bone pain May assist with functional stability
Nutritional Malabsorption, Low sunlight Contributes to systemic mineral balance

Regulatory References

  1. NIH MedlinePlus overview of Colecalciferol uses

Eligibility and Restrictions for Use

Official Population Eligibility for D-Pearls (Colecalciferol)

The use of D-Pearls is governed by official regulatory standards that define who is eligible and who is strictly prohibited from use. The preparation is generally permitted for adults and older adults, particularly those at documented risk of Vitamin D deficiency.

Eligibility Status Populations and Conditions
Contraindicated Use Must not be used in patients with Hypercalcaemia (high blood calcium), Hypercalciuria, or Hypervitaminosis D (excess Vitamin D levels). Use is also prohibited in patients with severe renal impairment, nephrolithiasis (kidney stones), or known hypersensitivity to the ingredients, including a peanut or soya allergy
Restricted Use Pregnancy and Lactation: High-strength formulations are typically not suitable or not recommended; overdose must be avoided. Impaired Renal Function (Non-Severe): Use requires caution and monitoring of calcium levels. Sarcoidosis: Requires caution due to the risk of increased Vitamin D sensitivity.
Age Limitations Specific capsule strengths are generally not recommended for children under 12 years of age. High-strength formulations are commonly contraindicated for use in individuals under 18 years of age.

Regulatory agencies define these eligibility requirements based on physiological risk, with the primary constraints tied to calcium and Vitamin D homeostasis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

D-Pearls (Cholecalciferol, or Vitamin D3) can interact with several medicinal products, primarily by affecting the body's calcium levels or the absorption and metabolism of the vitamin itself. These interactions may necessitate dose adjustments or increased clinical monitoring.

Interacting Product Category Mechanism of Interaction (Official Basis) Regulatory Caution Level
Thiazide Diuretics (e.g., Hydrochlorothiazide) Additive effect on calcium: reduced calcium excretion, increasing the risk of hypercalcemia (high calcium levels). Clinically Significant - Monitoring Required
Cardiac Glycosides (e.g., Digoxin) Vitamin D-induced hypercalcemia can intensify the effects of Digoxin, raising the risk of serious cardiac arrhythmias. Clinically Significant - Monitoring Required
Anticonvulsants (e.g., Phenytoin, Carbamazepine) Induce liver enzymes, increasing the breakdown (catabolism) of Vitamin D, potentially reducing its effectiveness and requiring a higher dose. Dose Adjustment/Monitoring Required
Corticosteroids (e.g., Prednisolone) May impair Vitamin D's absorption and activity, possibly leading to a reduced effect. Monitoring Required
Bile Acid Sequestrants (e.g., Cholestyramine) Interfere with fat-soluble vitamin absorption in the gut, thereby reducing Cholecalciferol absorption. Dosing separation is often required. Absorption Restriction

Restriction: The use of D-Pearls alongside other Vitamin D supplements or high-dose calcium salts is restricted due to the increased, additive risk of hypercalcemia. Patients taking this product must have their calcium and vitamin D levels regularly monitored when initiating or changing treatment with interacting medicines. This is especially critical for agents that affect calcium homeostasis.

Mechanism of Action

The mechanism of D-Pearls (Colecalciferol) is rooted in its function as a pro-hormone, requiring metabolic conversion to the active ligand, Calcitriol (1,25( OH)2 D3). Calcitriol works via a genomic mechanism by engaging the specific Vitamin D Receptor ( VDR) . This initiates a cascade of transcriptional changes that modulate physiological systems.

VDR Agonism and Gene Expression Modulation

Calcitriol acts as an agonist for the VDR, a nuclear receptor, forming a complex that binds directly to DNA to regulate the expression of target genes. This transcriptional modulation determines the production rate of essential regulatory proteins.

Regulation of Mineral Homeostasis

This addresses the primary systemic consequence of VDR activation across the intestine, kidney, and bone. By upregulating genes for transport proteins like Calbindin in the gut, the mechanism increases the active absorption of dietary calcium and phosphate. The net result is the maintenance of serum mineral concentrations necessary for bone matrix deposition and systemic physiological function.

️ Modulation of Non-Classical Systems

Beyond mineral handling, the mechanism extends to tissues expressing the VDR, including skeletal muscle and immune cells. This involves influencing gene transcription within these cells to contribute to the maintenance of muscle cell operational integrity and regulate the production of specific cytokines in the immune system.

Dosage and Administration Information

Instruction Map: How to use D-Pearls

Feature Instruction
Route of administration The product is used via oral administration.
Dosing schedule Use involves a low-dose range (e.g., 400 IU to 1,000 IU daily) for maintenance, and high-dose intermittent regimens (e.g., 50,000 IU weekly or monthly) for deficiency correction.
Timing in relation to meals The soft capsule is taken with a meal, typically the main meal of the day, to facilitate the absorption of the fat-soluble Colecalciferol.
Preparation requirements The soft capsule is swallowed whole with water and requires no prior dilution or preparation.
Age-group administration rules Pediatric use involves a specific, lower, age-adjusted dose that is distinct from adult maintenance and corrective regimens.
Missed-dose rules If a daily maintenance dose is missed, it is typically taken as soon as remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose is skipped.
Special procedural conditions Dose adjustment is guided by periodic monitoring of serum levels of Colecalciferol and calcium throughout both the corrective and maintenance phases.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral.
Frequency pattern Once daily for long-term maintenance, or intermittent (weekly, monthly) for the short-term corrective phase.
Use-context constraints Administration is characterized by the requirement for dietary fat intake and clinical laboratory monitoring to manage appropriate long-term dosing.

Resulting Procedural Structure

Step sequence:

  • The strength of D-Pearls used varies based on the current phase (correction or maintenance).
  • The capsule is swallowed whole with water, without being crushed or chewed.
  • The administration is accompanied by a meal to fulfill the absorption requirements of the active ingredient.
  • The dosage regimen is periodically reviewed and adjusted based on serum metabolite concentration results.

Connection to the overall use protocol: The protocol involves two phases: a high-dose, short-term intermittent regimen to address deficiency, followed by a low-dose, daily regimen for long-term maintenance. This usage pattern relies on proper oral administration with food to ensure the fat-soluble nature of the ingredient is accommodated. The procedure includes the requirement for periodic monitoring to guide dose modifications.

Recent Clinical Evidence

Research Evidence / Overview of Studies for D-Pearls

Evidence for Use in Skeletal Health and Bone Integrity

Research has extensively examined Colecalciferol for its relationship to skeletal health outcomes. Studies include numerous large-scale Randomized Controlled Trials (RCTs) and meta-analyses. This body of evidence was studied for its impact on conditions associated with deficiency, and research monitored outcomes such as changes in Bone Mineral Density (BMD), shifts in blood levels of the biomarker 25-hydroxyvitamin D [25(OH)D], and the frequency of fracture incidence. These studies included populations of older adults, post-menopausal women, and children in research focused on bone accrual.

Research describes patterns where the preparation was associated with measured increases in vitamin stores in observed populations. Data show patterns related to measured differences in fracture frequency in groups receiving the preparation and calcium compared to control groups, particularly in certain high-risk groups. Reports also describe research that monitored changes to BMD over observation periods spanning several years. However, research exploring fracture rates in the broader, unselected community show patterns related to varied findings, meaning results were not consistent across all trials.

Evidence for Muscle Function and Fall Prevention

Clinical trials have explored the relationship between Colecalciferol administration and physical performance, primarily in older adults. This research was studied for outcomes related to physical discomfort and functional imbalance. The trials measured functional performance and tracked overall muscle strength and monitored the subsequent incidence of falls.

Research highlights measured changes during the study period, with some trials reporting measurements related to muscle function in groups with documented deficiency. Data show patterns related to an association between Colecalciferol and changes in muscle strength measurements in these specific populations. However, evidence derived from settings with varying symptom burdens indicates that findings for the overall reduction of fall incidence were mixed across different scientific reviews.

What the Research Still Suggests is Uncertain

Research is ongoing, and several key uncertainties are consistently noted in systematic reviews. Findings were mixed concerning the general population's overall fracture risk reduction when Colecalciferol is used as a standalone intervention, indicating that certainty remains low for this broad application. Furthermore, evidence comparing long-term non-skeletal outcomes is limited, as most large RCTs primarily focused on assessing bone health. This means the research for many systemic support outcomes is limited.

Key Studies & References

  1. Cholecalciferol (Vitamin D3) - Uses
  2. Vitamin D and fall prevention in older adults: systematic review and meta-analysis of randomised controlled trials

Frequently Asked Questions (FAQ)

Common questions about D-Pearls (FAQ)

Q: What are the ingredients in D-Pearls besides the active component?

A: Official product information states that the active ingredient, Colecalciferol (Vitamin D3), is dissolved in a carrier oil, such as cold-pressed olive oil. This is then encapsulated within the soft capsule shell, which is typically composed of gelatin and glycerol. These components are considered non-active excipients.

Q: Is D-Pearls generally safe for people who are lactose intolerant?

A: Regulatory excipient lists generally indicate that this type of soft capsule formulation does not contain lactose or other dairy-derived ingredients. The main components beyond the active ingredient are the carrier oil and the gelatin capsule shell.

Q: What should be done if an expected but mild side effect occurs?

A: Official patient information often contains general guidance advising that any side effect experienced, even a mild or expected one, should be discussed with a healthcare professional or pharmacist. They can provide general advice on whether the reaction requires any change.

Q: Are there any common long-term side effects associated with D-Pearls use?

A: Regulatory documents define serious adverse reactions, such as effects on the kidneys and heart, that are generally associated with prolonged toxicity or overdose, rather than appropriate, monitored therapeutic use. The safety of long-term use is supported by the official requirement for periodic clinical monitoring of calcium and vitamin D levels.

Q: How long after stopping D-Pearls does it typically take for the effects to wear off?

A: The active substance and its primary metabolite have a long persistence in the body, with a half-life measured in weeks. Because of this long half-life, regulatory documents state that the effects of toxicity (from high intake) may persist for several weeks after the preparation is stopped.

Q: Is D-Pearls commonly recommended for people with limited sun exposure?

A: Official indications for Colecalciferol state that the product is intended to help prevent or treat Vitamin D deficiency. This often includes populations determined to be at a high risk due to factors like limited sunlight exposure or specific dietary habits.

Q: Is D-Pearls suitable for people following a vegetarian or vegan diet?

A: Due to its composition, the preparation is typically considered unsuitable for strict vegan or vegetarian diets. This is because the capsule is made from gelatin (animal-derived), and the Colecalciferol component is often manufactured from lanolin, which is derived from sheep's wool.

Q: Is it common for D-Pearls to cause a slight headache?

A: Headache is not listed in the official regulatory documents among the uncommon or rare adverse reactions associated with the preparation. The most commonly specified adverse events relate to metabolism (calcium levels) and the digestive system.

Q: Can D-Pearls be taken at the same time as a multivitamin?

A: Official guidance strongly advises against the concurrent use of D-Pearls alongside other Vitamin D supplements or high-dose calcium salts. This is due to the potential additive effect, which increases the risk of developing hypercalcaemia (high blood calcium levels).

Q: Does D-Pearls interact with common over-the-counter pain relievers?

A: Official regulatory interaction lists focus on specific categories of prescription drugs (e.g., thiazide diuretics) that affect calcium levels or Vitamin D breakdown. The official interaction lists do not typically include common over-the-counter pain relievers.

Q: Are there any known interactions between D-Pearls and alcohol consumption?

A: Official regulatory documents do not list alcohol consumption as a specific clinical interaction that requires a warning or dose adjustment for D-Pearls.

Q: Does D-Pearls interact with any commonly used herbal products?

A: Official regulatory interaction lists are typically restricted to prescription and specific over-the-counter drug classes. Commonly used herbal products are not listed in these documents as known interactions that require a warning or dose adjustment.

Q: Does taking D-Pearls affect the results of common blood tests?

A: The official procedure requires the periodic monitoring of serum levels of Colecalciferol (Vitamin D) and calcium. This is because the preparation is intended to adjust the blood levels of these specific substances.

Q: Is there a specific time of day that is generally considered optimal for taking D-Pearls?

A: Official instructions specify that the soft capsule must be taken with a meal, typically the main meal of the day, to ensure the adequate absorption of the fat-soluble active ingredient. No specific time (morning vs. evening) is designated as superior, only the requirement for food.

Q: Are there any food or drinks that are known to decrease the effectiveness of D-Pearls?

A: The preparation's effectiveness is structurally dependent on the presence of dietary fat for absorption. Official documents note that products which interfere with fat-soluble vitamin absorption in the gut (such as certain types of medication) can reduce the effectiveness of D-Pearls.

Q: What is the difference in purpose between D-Pearls and Calcium supplements?

A: D-Pearls (Colecalciferol) acts primarily as a regulator by increasing the body’s active absorption and utilization of calcium and phosphate from the diet. Calcium supplements, on the other hand, provide the actual mineral input that the preparation then helps the body absorb efficiently.

Q: Can people with liver function concerns generally use D-Pearls?

A: Official contraindications mainly focus on kidney impairment and high calcium levels. Liver function concerns are not usually listed as a primary contraindication, but specific health situations always require professional guidance before use.

Q: What is the maximum duration of use discussed in official D-Pearls documents?

A: Official instructions establish two distinct phases: a short-term corrective regimen and a long-term maintenance regimen. The long-term maintenance phase does not define a fixed maximum duration but requires periodic clinical monitoring to guide dose modifications.

Q: What is the significance of the 'pearl' color or size?

A: The preparation is referred to as 'Pearls' due to the small, easily swallowed shape of the soft gelatin capsule, which assists with oral administration. The color of the capsule is not assigned any functional significance in regulatory descriptions.

Q: Does D-Pearls cause unexpected weight changes?

A: Weight gain or weight loss is not listed in the official regulatory documents among the documented adverse reactions for the preparation.

Q: Do official sources provide any information on D-Pearls and mood?

A: Official regulatory documents do not list effects on mood, mental health, or psychological symptoms as a documented side effect or a target physiological outcome of the preparation.

Q: Is the active ingredient in D-Pearls animal- or plant-derived?

A: The Colecalciferol (Vitamin D3) component is commonly a derived substance manufactured from lanolin (sheep's wool), positioning it as an animal-derived product. The soft capsule also uses gelatin.

Q: Is it normal to experience mild gastrointestinal upset when first starting D-Pearls?

A: Official documentation lists gastrointestinal symptoms such as nausea and abdominal pain as rare adverse reactions. Official information does not specify if these symptoms are normal or transient upon starting treatment. Any side effect should be discussed with a healthcare professional.

Q: Have any studies examined the use of D-Pearls in pregnant or breastfeeding populations?

A: Regulatory guidelines restrict the use of high-strength formulations during pregnancy and lactation, advising that intake must not exceed necessary levels and that any use requires medical supervision. This restriction is based on an official assessment of risk for these groups.

How should D-Pearls be stored and disposed of?

How to Store and Dispose of D-Pearls (Colecalciferol)

Official regulatory guidelines strictly define the storage and disposal of Colecalciferol soft capsules to maintain product integrity and safety.


Mandatory Storage Requirements

Requirement Official Instruction
Temperature Store at room temperature, generally below 30 C (86 F). Do not refrigerate or freeze.
Protection Protect from light and moisture; keep the container tightly closed and in the original packaging.
Child Safety Keep out of the sight and reach of children.
Stability Do not use after the expiry date (EXP).

Official Disposal Rules

Unused or expired D-Pearls must be discarded according to regulatory standards. Do not throw away any medicines via wastewater or household waste. Consult a pharmacist for instructions on how to properly throw away medicines no longer needed, following local pharmaceutical waste protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of D-Pearls found in:

A-Z Index: